Evidence map›Paper›PMID 24112301›Full record

ReviewMicrocirculation (New York, N.Y. : 1994)2014

Myosin phosphatase isoforms as determinants of smooth muscle contractile function and calcium sensitivity of force production.

Rachael P Dippold, Steven A Fisher

Open access · greenAbstract readReview
In one paragraph

Review in Microcirculation (New York, N.Y. : 1994), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Calcium Sensitization Mechanisms in Gastrointestinal Smooth Muscles.Journal of neurogastroenterology and motility · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Neural programming of mesenteric and renal arteries.American journal of physiology. Heart and circulatory physiology · 2014
    Article
  19. A bioinformatic and computational study of myosin phosphatase subunit diversity.American journal of physiology. Regulatory, integrative and comparative physiology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rachael P DippoldDepartment of Medicine (Cardiology), University of Maryland Baltimore, Baltimore, Maryland, USA.
Steven A Fisher
University of Maryland, Baltimore · US

Funding

Interdisciplinary Training Program Muscle BiologyT32AR007592 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Aikaterini Kontrogianni-Konstantopoulos · 1996 to 2026
$11.7M
SMOOTH MUSCLE MYOSIN PHOSPHATASE SUBUNIT ISOFORMSR01HL066171 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI FISHER, STEVEN A. · 2001 to 2013
$3.8M
NHLBI NIH HHS HL66171NHLBI NIH HHS R01 HL066171NIAMS NIH HHS T32 AR007592
6 · The paper itself

Abstract

The dephosphorylation of myosin by the MP causes smooth muscle relaxation. MP is also a key target of signals that regulate vascular tone and thus blood flow and pressure. Here, we review studies from the past two decades that support the hypothesis that the regulated expression of MP subunits is a critical determinant of smooth muscle responses to constrictor and dilator signals. In particular, the highly regulated splicing of the regulatory subunit Mypt1 Exon 24 is proposed to tune sensitivity to NO/cGMP-mediated relaxation. The regulated transcription of the MP inhibitory subunit CPI-17 is proposed to determine sensitivity to agonist-mediated constriction. The expression of these subunits is specific in the microcirculation and varies in developmental and disease contexts. To date, the relationship between MP subunit expression and vascular function in these different contexts is correlative; confirmation of the hypothesis will require the generation of genetically engineered mice to test the role of MP subunits and their isoforms in the specificity of vascular smooth muscle responses to constrictor and dilator signals.

Indexed as

AnimalsCalcium SignalingHumansIntracellular Signaling Peptides and ProteinsIsoenzymesMiceMicrovesselsModels, CardiovascularMuscle ContractionMuscle ProteinsMuscle, Smooth, VascularMyosin-Light-Chain KinaseMyosin-Light-Chain PhosphatasePhosphoproteinsProtein SubunitsSignal TransductionIntracellular Signaling Peptides and ProteinsIsoenzymesMuscle ProteinsMyosin-Light-Chain KinaseMyosin-Light-Chain PhosphatasePhosphoproteinsPpp1r12a protein, mousePpp1r14a protein, mouseProtein SubunitscGMPCPI-17myosin phosphataseMypt1NOPKG1vascular smooth muscle

Identifiers

PMID24112301
PMCPMC4349328
OpenAlexW2012855371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.